Indonesia stocks lower at close of trade IDX Composite Index down 0.77 percent - Investing.com
| SDPC Stock | IDR 173.00 10.00 6.13% |
About 55% of Millennium Pharmacon's institutional investors are presently thinking to get in. The analysis of current outlook of investing in Millennium Pharmacon International suggests that some traders are interested regarding Millennium Pharmacon's prospects. Millennium Pharmacon's investing sentiment shows overall attitude of investors towards Millennium Pharmacon International.
Millennium |
Indonesia stocks lower at close of trade IDX Composite Index down 0.77 Investing.com
Read at news.google.com
 |
Millennium Pharmacon Fundamental Analysis
We analyze Millennium Pharmacon's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Millennium Pharmacon using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Millennium Pharmacon based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
Millennium Pharmacon is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Millennium Pharmacon Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Millennium Pharmacon stock to make a market-neutral strategy. Peer analysis of Millennium Pharmacon could also be used in its relative valuation, which is a method of valuing Millennium Pharmacon by comparing valuation metrics with similar companies.
Peers
Millennium Pharmacon Related Equities
| HEXA | Hexindo Adiperkasa | 0.63 | ||||
| CMNP | Citra Marga | 0.35 | ||||
| DVLA | Darya Varia | 0.31 | ||||
| LTLS | Lautan Luas | 0.99 | ||||
| ASGR | Astra Graphia | 1.71 |
Other Information on Investing in Millennium Stock
Millennium Pharmacon financial ratios help investors to determine whether Millennium Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Millennium with respect to the benefits of owning Millennium Pharmacon security.